Use of BCG in Immunotherapy of Superficial Bladder Cancer: Multicentric Investigation on Safety and Compliance

References

• Ross R.K. Jones P.A. Yu M.C. 1996 Bladder cancer epidemiology and pathogenesis Semin. Oncol. 23 5 536 545
   Google Scholar
• Mungan N.A. Kiemeney L.A. van Dijck J.A. van der Poel H.G. Witjes J.A. 2000 Gender differences in stage distribution of bladder cancer Urology 55 3 368 371
   Google Scholar
• Micheli A. Mariotto A. Giorgi Rossi A. Gatta G. Muti P. 1998 The prognostic role of gender in survival of adult cancer patients Eur. J. Cancer 34 14 2271 2278
   Google Scholar
• Mungan N.A. Aben K.K. Schoenberg M.P. Visser O. Coebergh J.W. Witjes J.A. Kiemeney L.A. 2000 Gender differences in stage-adjusted bladder cancer survival Urology 55 6 876 880
   Google Scholar
• Castelao J.E. Yuan J.M. Skipper P.L. Tannenbaum S.R. Gago-Dominguez M. Crowder J.S. Ross R.K. Yu M.C. 2001 Gender- and smoking-related bladder cancer risk J. Natl Cancer Inst. 93 7 538 545
   Google Scholar
• Shapiro J.A. Jacobs E.J. Thun M.J. 2000 Cigar smoking in men and risk of death from tobacco-related cancers J. Natl Cancer Inst. 92 4 333 337
   Google Scholar
• Fleshner N. Garland J. Moadel A. Herr H. Ostroff J. Trambert R. O'Sullivan M. Russo P. 1999 Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder Cancer 86 11 2337 2345
   Google Scholar
• Mikhailidis D.P. Ganotakis E.S. Papadakis J.A. Jeremy J.Y. 1998 Smoking and urological disease J. R. Soc. Health 118 4 210 212
   Google Scholar
• Raitanen M.P. Nieminen P. Tammela T.L. 1995 Impact of tumor grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder Br. J. Urol. 76 4 470 474
   Google Scholar
• Lamm D.I. 1992 Long-term results of intravesical therapy for superficial bladder cancer Urol. Clin. N. Am. 19 3 573
   Google Scholar
• Herr H.W. 1997 Management of Superficial Bladder Cancer in Principles and Practice of Genitourinary Oncology Lippincott-Raven Philadelphia
   Google Scholar
• Morgia G. Mauceri G. Mazzone G. Motta M. 1992 Retrospective analysis on drug tolerance in the prophylaxis of superficial urothelioma neoplastic recurrence Arch. Ital. Urol. 64 313 317
   Google Scholar
• Lamm D.L. Steg A. Boccon Gibod F. 1989 Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications, BCG in Superficial Bladder Cancer EORTC Genitourinary Monograph 6, Alan R Liss Inc. New York 335 355
   Google Scholar
• Lamm D.L. 1992 Incidence and treatment of complication of BCG intravesical therapy in superficial bladder cancer J. Urol. 147 596
   Google Scholar
• Berry D.L. Blumenstain B.A. Magyary D.L. Lamm D.L. Crawford E.D. 1996 Local toxicity patterns associated with intravesical BCG: a Southwest Oncology Group Study Int. J. Urol. 3 2 98 100
   Google Scholar
• Bohle A. Balk F. Von Weitesheim J. Jocham D. 1996 The quality of life during intravesical BCG therapy J. Urol. 155 1221 1226
   Google Scholar
• Mack D. Frick J. 1996 Quality of life in patients undergoing BCG therapy for superficial bladder cancer Br. J. Urol. 78 369 371
   Google Scholar
• Morgia G. Motta M. Pianezza O. Bono A.V. 1999 Aspetti e qualità di vita dei pazienti trattati con BCG, BCG 2000 Verduci Editore 69 81
   Google Scholar